(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) jumped 8.29% to $6.92 at 06:36 EST on Thursday, following the last session’s upward trend. NASDAQ Composite is rising 2.15% to $15,565.58, after five sequential sessions in a row of losses. This seems, so far, an all-around bullish trend trading session today.

Catalyst Pharmaceuticals’s last close was $6.92, 8.71% under its 52-week high of $7.58.


Today’s last reported volume for Catalyst Pharmaceuticals is 1509337 which is 63.17% above its average volume of 924975.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the ongoing quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.12%, a negative 0.98%, and a positive 2.42%, respectively.

Catalyst Pharmaceuticals’s highest amplitude of average volatility was 1.99% (last week), 2.12% (last month), and 2.42% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $6.92 at 06:36 EST, below its 52-week high of $7.58 and way above its 52-week low of $3.27.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is higher than its 50-day moving average of $6.53 and way above its 200-day moving average of $5.51.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here